In Vitro and In Vivo Evaluation of Cysteine Rebridged Trastuzumab–MMAE Antibody Drug Conjugates with Defined Drug-to-Antibody Ratios
-
- Penny Bryant
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Martin Pabst
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- George Badescu
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Matthew Bird
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- William McDowell
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Estera Jamieson
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Julia Swierkosz
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Kosma Jurlewicz
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Rita Tommasi
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Korinna Henseleit
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- XiaoBo Sheng
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Nicolas Camper
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Anais Manin
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Katarzyna Kozakowska
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Karolina Peciak
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Emmanuelle Laurine
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Ruslan Grygorash
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Andrew Kyle
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- David Morris
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Vimal Parekh
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Amrita Abhilash
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Ji-won Choi
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Jeff Edwards
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Mark Frigerio
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Matthew P. Baker
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
-
- Antony Godwin
- PolyTherics Ltd. and ‡Antitope Ltd., Abzena, Babraham Research Campus, CB22 3AT Cambridge, United Kingdom
収録刊行物
-
- Molecular Pharmaceutics
-
Molecular Pharmaceutics 12 (6), 1872-1879, 2015-05-05
American Chemical Society (ACS)
